263.15
3.35
(1.29%)
07/17/2026
Ascendis Pharma A/S (ASND)
Trading Data | |
| Close | 263.15 |
| Open | 259.61 |
| High | 267.50 |
| Low | 259.50 |
| Volume | 453,853 |
| Change | 3.35 |
| Change % | 1.29 |
| Avg Volume (20 Days) | 881,574 |
| 52 Week Range | 160.86 - 281.79 |
| Price vs 52 Week High | -6.61% |
| Price vs 52 Week Low | 63.59% |
| Range | -2.84 |
| Gap Up/Down | -1.45 |
| Beta | 0.4480 |
Volume | |
| Volume 1 Day Change | -25,046 |
| Volume 1 Day Change (%) | -15.41 |
| Avg Volume 1 Week | 476,397 |
| Avg Volume 20 Days | 881,574 |
Fundamentals | |
| Market Capitalization (Mln) | 12,044 |
| EBIDTA | -448,988,000 |
| PE Ratio | 0.0000 |
| PEG Ratio | 0.0000 |
| WallStreet Target Price | 180.47 |
| Book Value | -2.5730 |
| Earnings Per Share | |
| EPS Estimate Current Quarter | |
| EPS Estimate Next Quarter | |
| EPS Estimate Current Year | |
| EPS Estimate Next Year | |
| Diluted EPS (TTM) | |
| Revenues | |
| Profit Marging | |
| Operating Margin (TTM) | |
| Return on asset (TTM) | |
| Return on Equity (TTM) | |
| Revenue TTM | |
| Revenue / Share (TTM) | |
| Quarterly Revenue Growth (YOY) | |
| Quarterly Earnings Growth (YOY) | |
| Gross Profit (TTM) | |
| Dividends | |
| Dividend Share | 0.0000 |
| Dividend Yield | |
| Valuations | |
| Trailing PE | |
| Forward P/E | |
| Price Sales (TTM) | |
| Price Book MRQ | |
| Revenue Enterprise Value | |
| EBITDA Enterprise Value | |
| Shares | |
| Shares Outstanding | |
| Shares Float | |
| Shares Short | |
| Shares Short (Prior Month) | |
| Shares Ratio | |
| Short Outstanding (%) | |
| Short Float (%) | |
| Insider (%) | |
| Institutions (%) | |